Cargando…
New Pharmacologic Approaches to Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia is the most common long-term respiratory morbidity of preterm infants, with the risk of development proportional to the degree of prematurity. While its pathophysiologic and histologic features have changed over time as neonatal demographics and respiratory therapies have...
Autores principales: | Roberts, Katelyn, Stepanovich, Gretchen, Bhatt-Mehta, Varsha, Donn, Steven M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006962/ https://www.ncbi.nlm.nih.gov/pubmed/33790663 http://dx.doi.org/10.2147/JEP.S262350 |
Ejemplares similares
-
Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches
por: Michael, Zoe, et al.
Publicado: (2018) -
Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia
por: Tropea, Kristen, et al.
Publicado: (2012) -
Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020) -
A bioinformatics approach towards bronchopulmonary dysplasia
por: Valadie, Charles Taylor, et al.
Publicado: (2023) -
Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)